Amazon cover image
Image from Amazon.com

The delivery of regenerative medicines and their impact on healthcare [electronic resource] / edited by Catherine D. Prescott, Dame Julia Polak.

Contributor(s): Material type: TextPublication details: Boca Raton : CRC Press/Taylor & Francis, 2011.Description: xvi, 400 p. : ill., portsISBN:
  • 9781439836071 (ebook : PDF)
Subject(s): Genre/Form: Additional physical formats: No titleOnline resources: Available additional physical forms:
  • Also available in print edition.
Contents:
section 1. Introduction -- section 2. Finance -- section 3. Business models -- section 4. Intellectual property -- section 5. Regulatory landscape -- section 6. Reimbursement -- section 7. Insurance and risk management.
Summary: "Based on input from an international panel of experts, this book provides first-hand experience of the challenges and opportunities facing the delivery of regenerative medicines to patients. It highlights key issues beyond science and clinical translation, such as finance and business models, intellectual property and regulatory landscapes as well as questions of how regenerative medicines will be evaluated for reimbursement. This book will become a pivotal reference to anyone within the healthcare sector interested in understanding and investing in the delivery of regenerative medicines to the benefit of patients"--Provided by publisher.
Item type:
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Includes bibliographical references and index.

section 1. Introduction -- section 2. Finance -- section 3. Business models -- section 4. Intellectual property -- section 5. Regulatory landscape -- section 6. Reimbursement -- section 7. Insurance and risk management.

"Based on input from an international panel of experts, this book provides first-hand experience of the challenges and opportunities facing the delivery of regenerative medicines to patients. It highlights key issues beyond science and clinical translation, such as finance and business models, intellectual property and regulatory landscapes as well as questions of how regenerative medicines will be evaluated for reimbursement. This book will become a pivotal reference to anyone within the healthcare sector interested in understanding and investing in the delivery of regenerative medicines to the benefit of patients"--Provided by publisher.

Also available in print edition.

Mode of access: World Wide Web.

There are no comments on this title.

to post a comment.
Share